EP3151921
Mótefni gegn GITR (e.Glucocorticoid-Induced Tumor Necrosis Factor Receptor) og notkun þeirra
:
EP Einkaleyfi fallið úr gildi:
3.6.2015:
28.8.2019:
15742414.4
:
22.11.2019:
15.12.2019
:
2.6.2035:
2.6.2024
:
ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
3.6.2015
28.8.2019
22.11.2019
15.12.2019
2.6.2024
:
Bristol-Myers Squibb Company:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
:
WANG, Changyu:
Union City, CA, US
:
LONBERG, Nils:
Redwood City, CA, US
:
KORMAN, Alan J.:
Redwood City, CA, US
:
SELBY, Mark J.:
Redwood City, CA, US
:
SRINIVASAN, Mohan:
Redwood City, CA, US
:
HENNING, Karla:
Redwood City, CA, US
:
HAN, Michelle, Minhua:
Redwood City, CA, US
:
CHEN, Guodong:
Princeton, NJ, US
:
HUANG, Richard:
Princeton, NJ, US
:
CHAKRABORTY, Indrani:
Redwood City, CA, US
:
HUANG, Haichun:
Redwood City, California, US
:
WONG, Susan:
Redwood City, California, US
:
LI, Huiming:
Waltham, MA, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201462008945 P:
6.6.2014:
US
:
201462082980 P:
21.11.2014:
US
:
US2015033991:
3.6.2015
:
A61P 35/00, A61K 39/00, C07K 16/28
: 6
: 5.5.2020
: 2.6.2021
: Árnason Faktor ehf.
: 7
: 11.5.2021
: 2.6.2022
: Árnason Faktor ehf.
: 8
: 6.5.2022
: 2.6.2023
: Árnason Faktor ehf.
: 9
: 24.5.2023
: 2.6.2024
: Árnason Faktor ehf.